Turn Therapeutics Inc. (TTRX) - Form 8-K Summary
Business Context and Reporting Period
This is a Current Report on Form 8-K filed by Turn Therapeutics Inc., a Delaware corporation and emerging growth company, on November 12, 2025. The report covers events occurring on November 11, 2025. The company is headquartered in Westlake Village, California, and its common stock trades on The Nasdaq Stock Market LLC under the symbol "TTRX."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure vehicle for press releases rather than a financial statement.
Material Changes
The primary material event reported is the issuance of two press releases on November 11, 2025, under Item 7.01 (Regulation FD Disclosure). The content of these releases is attached as Exhibits 99.1 and 99.2 but is not summarized within the body of this 8-K text.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, financial guidance, or risk factors within the main text. It explicitly states that the information in Item 7.01 and the attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Exchange Act unless specifically incorporated by reference.
Key Facts for Investor Verification
- Verify the specific content of the two press releases (Exhibits 99.1 and 99.2) to understand the nature of the material disclosure.
- Confirm whether the press release information has been incorporated by reference into other filings to determine liability under Section 18 of the Exchange Act.
- Note the company's status as an emerging growth company, which may affect financial reporting requirements.